Año: 2018
Journal Impact Factor (JIF): 14.1960
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 9/230 | Q1 | T1 | D1 |
Año: 2018
Journal Citation Indicator (JCI): 2,780
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 9/302 | Q1 | T1 | D1 | 97,19 |
Año:
2018
CiteScore:
20,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 2/122 | Q1 | T1 | D1 |
| Oncology | 9/323 | Q1 | T1 | D1 |
SJR año:
2018
Factor de Impacto:
6,047
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Hematology | 3/142 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 33/2805 | Q1 | T1 | D1 |
| Oncology | 8/401 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Adaptaimmune | - |
| Advenchen | - |
| Amcure | - |
| Amgen | - |
| Amgen Dompe | - |
| AROG Bayer | - |
| AstraZeneca | - |
| Bayer | - |
| Blueprint Medicines | - |
| Boehringer Ingelheim | - |
| Bristol-Myers Squibb | - |
| CoBioRes | - |
| Cristal Therapeutics | - |
| Daichii Sankyo Pharma | - |
| Daiichi Sankyo Pharma | - |
| Eisai | - |
| Eli Lilly | - |
| Epizyme | - |
| Epizyme Inc. | - |
| EuroSarc | - |
| Exelixis | - |
| Genzyme | - |
| GlaxoSmithKline | - |
| Incyte | - |
| Ipsen | - |
| Janssen-Cilag | - |
| Lilly | - |
| Loxo Oncology | - |
| Medpace | - |
| Menarini | - |
| Merck Sharp Dohme | - |
| Milestone | - |
| Nanobiotix | - |
| Nektar | - |
| Novartis | - |
| Novartis Oncology | - |
| Pfizer | - |
| PharmaMar | - |
| PharmarMar | - |
| Philogen | - |
| Piqur Therapeutics | - |
| Plexxikon | - |
| Roche | - |
| Sixth Element Capital | - |
| Swedish Orphan Biovitrium | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy) | |
| 2 | Abecassis, N | EPE (Portugal) |
| 3 | Bauer, S | University of Duisburg Essen (Germany) |
| 4 | Biagini, R | IRCCS Istituti Fisioterapici Ospitalieri (IFO) (Italy) |
| 5 | Bielack, S | General Hospital of N. Ionia Agia Olga (Germany) |
| 6 | Bonvalot, S | UNICANCER (France) |
| 7 | Boukovinas, I | NORDIX (Greece) |
| 8 | Bovee, JVMG | Leiden University (Netherlands) |
| 9 | Brodowicz, T | Medical University of Vienna (Austria) |
| 10 | Broto, JM | CIBER - Centro de Investigacion Biomedica en Red (Spain) |
| 11 | Buonadonna, A | IRCCS Aviano (CRO) (Italy) |
| 12 | Alava, E | CIBER - Centro de Investigacion Biomedica en Red (Spain) |
| 13 | Tos, AP | Osped Reg Treviso S Maria Ca Foncello (Italy) |
| 14 | Muro, XG | Catalan Health Institute (Spain) |
| 15 | Dileo, P | University College London Hospitals NHS Foundation Trust (England) |
| 16 | Eriksson, M | Lund University (Sweden) |
| 17 | Fedenko, A | N.N. Blokhin Russian Cancer Research Center (Russia) |
| 18 | Ferraresi, V | Inst Sci Hosp Care (Italy) |
| 19 | Ferrari, A | Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy) |
| 20 | Ferrari, S | IRCCS Istituto Ortopedico Rizzoli (Italy) |
| 21 | Frezza, AM | University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy) |
| 22 | Gasperoni, S | Univ Careggi Firenze (Italy) |
| 23 | Gelderblom, H | Leiden University (Netherlands) |
| 24 | Gil, T | Institut Jules Bordet (Belgium) |
| 25 | Grignani, G | IRCCS Fondazione del Piemonte per l'Oncologia (Italy) |
| 26 | Gronchi, A | University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy) |
| 27 | Haas, RL | Leiden University; Netherlands Cancer Institute (Netherlands) |
| 28 | Hannu, A | University of Turku (Finland) |
| 29 | Hassan, B | Oxford University Hospitals NHS Foundation Trust (England) |
| 30 | Hohenberger, P | Ruprecht Karls University Heidelberg (Germany) |
| 31 | Issels, R | University of Munich (Germany) |
| 32 | Joensuu, H | University of Helsinki (Finland) |
| 33 | Jones, RL | Royal Marsden NHS Foundation Trust (England) |
| 34 | Judson, I | Royal Marsden NHS Foundation Trust (England) |
| 35 | Jutte, P | University of Groningen (Netherlands) |
| 36 | Kaal, S | Radboud University Nijmegen (Netherlands) |
| 37 | Kasper, B | Ruprecht Karls University Heidelberg (Germany) |
| 38 | Kopeckova, K | Motol University Hospital (Czech Republic) |
| 39 | Krakorova, DA | Masaryk Memorial Cancer Institute (Czech Republic) |
| 40 | Cesne, A | UNICANCER (France) |
| 41 | Lugowska, I | Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology (Poland) |
| 42 | Merimsky, O | Tel Aviv Sourasky Med Ctr Ichilov (Israel) |
| 43 | Montemurro, M | University of Lausanne (Switzerland) |
| 44 | Pantaleo, MA | University of Bologna (Italy) |
| 45 | Piana, R | A.O.U. Citta della Salute e della Scienza di Torino (Italy) |
| 46 | Picci, P | IRCCS Istituto Ortopedico Rizzoli (Italy) |
| 47 | Piperno-Neumann, S | UNICANCER (France) |
| 48 | Pousa, AL | Hospital of Santa Creu i Sant Pau (Spain) |
| 49 | Reichardt, P | Helios Kliniken (Germany) |
| 50 | Robinson, MH | Weston Park Hospital (England) |
| 51 | Rutkowski, P | Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology (Poland) |
| 52 | Safwat, AA | Aarhus University (Denmark) |
| 53 | Schoffski, P | Leuven Canc Inst (Belgium) |
| 54 | Sleijfer, S | Erasmus University Rotterdam (Netherlands) |
| 55 | Stacchiotti, S | Fondazione IRCCS Istituto Nazionale Tumori Milan (Italy) |
| 56 | Hall, KS | University of Oslo (Norway) |
| 57 | Unk, M | Institute of Oncology - Slovenia (Slovenia) |
| 58 | Coevorden, F | Netherlands Cancer Institute (Netherlands) |
| 59 | Graaf, WD | Royal Marsden NHS Foundation Trust (England) |
| 60 | Whelan, J | University of London (England) |
| 61 | Wardelmann, E | University of Munster (Germany) |
| 62 | Zaikova, O | University of Oslo (Norway) |
| 63 | Blay, JY | Université Claude Bernard Lyon 1; UNICANCER (France) |
